Shandong Keyuan Pharmaceutical Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 6.44%

Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has an Asset Resilience Ratio of 6.44% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Shandong Keyuan Pharmaceutical Co. Ltd. 's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥103.29 Million

≈ $15.11 Million USD Cash + Short-term Investments

Total Assets

CN¥1.60 Billion

≈ $234.77 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2023–2024)

This chart shows how Shandong Keyuan Pharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Shandong Keyuan Pharmaceutical Co. Ltd. balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Shandong Keyuan Pharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 301281 total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥103.29 Million	6.44%
Total Liquid Assets	CN¥103.29 Million	6.44%

Asset Resilience Insights

Limited Liquidity: Shandong Keyuan Pharmaceutical Co. Ltd. A maintains only 6.44% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shandong Keyuan Pharmaceutical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shandong Keyuan Pharmaceutical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
AstraZeneca PLC F:ZEGA	Drug Manufacturers - General	0.03%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%
Biogen Inc NASDAQ:BIIB	Drug Manufacturers - General	0.00%

Annual Asset Resilience Ratio for Shandong Keyuan Pharmaceutical Co. Ltd. A (2023–2024)

The table below shows the annual Asset Resilience Ratio data for Shandong Keyuan Pharmaceutical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	16.39%	CN¥254.43 Million ≈ $37.23 Million	CN¥1.55 Billion ≈ $227.18 Million	+6.15pp
2023-12-31	10.24%	CN¥150.54 Million ≈ $22.03 Million	CN¥1.47 Billion ≈ $215.10 Million	--

pp = percentage points

About Shandong Keyuan Pharmaceutical Co. Ltd. A

SHE:301281 China Drug Manufacturers - General

Market Cap

$786.13 Million

CN¥5.37 Billion CNY

Market Cap Rank

#10033 Global

#2634 in China

Share Price

CN¥49.61

Change (1 day)

-1.76%

52-Week Range

CN¥26.26 - CN¥58.05

All Time High

CN¥59.70